Top

Published in:

01-06-2005 | Letter to the editor

The BRCA1 exon 13 duplication in the Swedish population

Authors: Barbara Kremeyer, Maria Soller, Kristina Lagerstedt, Paula Maguire, Sylvie Mazoyer, Margareta Nordling, Jan Wahlström, Annika Lindblom

Published in: Familial Cancer | Issue 2/2005

Title: The BRCA1 exon 13 duplication in the Swedish population
Authors: Barbara Kremeyer
Maria Soller
Kristina Lagerstedt
Paula Maguire
Sylvie Mazoyer
Margareta Nordling
Jan Wahlström
Annika Lindblom
Publication date: 01-06-2005
Publisher: Kluwer Academic Publishers
Published in: Familial Cancer / Issue 2/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-004-7023-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2005

Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH

The CHEK2 1100delC allele is not relevant for risk assessment in HNPCC and HBCC Spanish families

A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques

The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds

A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history

Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer